CN1965939A - Externally applied formulation for treating skin amyloidosis - Google Patents
Externally applied formulation for treating skin amyloidosis Download PDFInfo
- Publication number
- CN1965939A CN1965939A CNA2006101021424A CN200610102142A CN1965939A CN 1965939 A CN1965939 A CN 1965939A CN A2006101021424 A CNA2006101021424 A CN A2006101021424A CN 200610102142 A CN200610102142 A CN 200610102142A CN 1965939 A CN1965939 A CN 1965939A
- Authority
- CN
- China
- Prior art keywords
- gram
- grams
- treatment
- external preparation
- distilled water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an external agent for treating amyloidosis of skin, wherein its active components comprise 70-150g pokeberry, 100-200g black plum, 300-400g gallnut, 200-300g dittany bark, 70-140g centella, and 1-3g camphor. And the production comprises that: putting into boiling container, adding 4000-5000ml distilled water, boiling for more than 10h with warm fire; filtering out slag; evaporating, and breaking the left solid into powder, mixing 50g powder, 10g trolamine, 10g ethal, 100g Vaseline, 93g stearic acid, 93g monostearate, 1g methyl-p-hydroxybenzoate ethyl, 40g glycerin, and 440ml distilled water, into external agent which uses oil to pack water. The inventive agent has no toxicity and no side effect.
Description
One, technical field
The present invention relates to the dermopathic external preparation of a kind of treatment, is the dermopathic external-application cream of a kind of treatment amyloidosis.
Two, background technology
At present, though it is a lot of to be used for the treatment of the medicine for external use of amyloidosis, cream, tincture etc. are arranged, but all contain hormone medicine in these medicines, life-time service can have side effects, particularly because the dermopathic cortex of amyloidosis is thicker, when removing larger area pathological changes cortex, not only side effect is big, and removal effect is bad, thereby cause long-time medication, bring bigger side effect.Existing in addition medicine can not be eradicated the amyloidosis dermatosis, cures easily recurrence of back.
Three, summary of the invention
The purpose of this utility model is to overcome the deficiencies in the prior art, a kind of good effect is provided, has no side effect, the external preparation of the treatment skin amyloidosis of non-relapse after healing.
The purpose of the technology of the present invention can realize by following scheme: its active ingredient of making is Radix Phytolaccae 70-150 gram, Fructus Gleditsiae Abnormalis 50-100 gram, Fructus Mume 100-200 gram, Galla Chinensis 300-400 gram, Cortex Dictamni 200-300 gram, Herba Centellae 70-140 gram, Camphora 1-3 gram, its processing technology is: the medicine of above-mentioned each component is put into the container of boiling medicine, add the 4000-5000 ml distilled water, with at a simmer more than 10 hours, elimination slag then, whole water evaporates of medicinal liquid are fallen, remaining solid drugs behind the transpiring moisture is crushed into powder, gets powder 50 grams and triethanolamine 10 grams, hexadecanol 10 grams, vaseline 100 grams, stearic acid 93 grams, monostearate 93 grams, ethyl hydroxybenzoate 1 gram, peregal 3 grams, glycerol 40 grams, 440 milliliters of mix homogeneously of distilled water are made water in oil external-application cream.
The purpose of the technology of the present invention can also realize by following scheme:
Its active ingredient of making is Radix Phytolaccae 90-120 gram, Fructus Gleditsiae Abnormalis 60-80 gram, Fructus Mume 120-170 gram, Galla Chinensis 320-360 gram, Cortex Dictamni 230-280 gram, Herba Centellae 90-140 gram, Camphora 1-2 gram.
Its active ingredient of making is Radix Phytolaccae 100 grams, Fructus Gleditsiae Abnormalis 70 grams, Fructus Mume 150 grams, Galla Chinensis 350 grams, Cortex Dictamni 250 grams, Herba Centellae 100 grams, Camphora 1 gram.
It is the stifling extraction of the concentrated solution solid drugs that will fry in shallow oil the back filtering residue that medicinal liquid evaporates, or whole moisture extraction solid drugs are fallen in the concentrated solution natural evaporation of filtering residue after will frying in shallow oil.
The present invention compared with prior art has following advantage:
1, the active component of making this medicament is a Chinese medicine all, has no side effect, and therapeutic effect is good, short treating period, non-relapse after healing.
2, the present invention can make cream or tincture, and is easy to use, but large tracts of land is used.
3, preparation stable performance.
4, the present invention have dispelling wind for relieving itching, hard masses softening and resolving, the effect of the rhythm skin that nourishes blood, can treat all kinds skin amyloidosis.
Using method of the present invention:
1, external, is applied to the affected part outward with cream or tincture at every day 1-2 time.
2, be a course of treatment January.Cured in general three months to come the more.
The present invention proves that through thousands of routine clinical trials cure rate 90%, effective percentage 98% have no side effect.
Introduce below and use three model cases of the present invention:
1, Korea Spro XX, man, 54 years old, He Si people from village, Chengan County, Hebei province, in year surplus in the of ill 20, the multi-treatment poor effect is used the skin lesion attenuation after 45 days of this topical agent, is not itched basic recovery normally, the healing bimester of the decrement treatment.
2, Wu X, woman, 37 years old, Xi Ma people from village, Chengan County, Hebei province, for many years ill, use this topical agent to cure March.
3,3 Lee X, man, 23 years old, Gu Ma people from village, Chengan County, Hebei province, for many years ill, use this topical agent to cure in 2 years, there is not recurrence.
Four, the specific embodiment
Below by of the present invention ten specific embodiments of lists, Chinese medicine component among each embodiment is pharmacy and buys, its processing technology is puts into the container of boiling medicine with the medicine of each component, add the 4000-5000 ml distilled water, with at a simmer more than 10 hours, elimination slag then, whole water evaporates of medicinal liquid are fallen, remaining solid drugs behind the transpiring moisture is crushed into powder, gets powder 50 grams and triethanolamine 10 grams, hexadecanol 10 grams, vaseline 100 grams, stearic acid 93 grams, monostearate 93 grams, ethyl hydroxybenzoate 1 gram, peregal 3 grams, glycerol 40 grams, 440 milliliters of mix homogeneously of distilled water are made water in oil external-application cream.It is the stifling extraction of the concentrated solution solid drugs that will fry in shallow oil the back filtering residue that medicinal liquid evaporates, or whole moisture extraction solid drugs are fallen in the concentrated solution natural evaporation of filtering residue after will frying in shallow oil.
The processing technology of enumerating among the embodiment is to get powder 50 grams of solid drugs, be convenient for example, in practical operation with the blended triethanolamine of drug powder, hexadecanol, vaseline, stearic acid, monostearate, ethyl hydroxybenzoate, peregal, glycerol, distilled water in this ratio equal proportion proportioning.Each component can amplify in proportion in batch production process.
Unit: gram
Claims (4)
1, a kind of external preparation for the treatment of skin amyloidosis, it is characterized in that: its active ingredient of making is Radix Phytolaccae 70-150 gram, Fructus Gleditsiae Abnormalis 50-100 gram, Fructus Mume 100-200 gram, Galla Chinensis 300-400 gram, Cortex Dictamni 200-300 gram, Herba Centellae 70-140 gram, Camphora 1-3 gram, its processing technology is: the medicine of above-mentioned each component is put into the container of boiling medicine, add the 4000-5000 ml distilled water, with at a simmer more than 10 hours, elimination slag then, whole water evaporates of medicinal liquid are fallen, remaining solid drugs behind the transpiring moisture is crushed into powder, gets powder 50 grams and triethanolamine 10 grams, hexadecanol 10 grams, vaseline 100 grams, stearic acid 93 grams, monostearate 93 grams, ethyl hydroxybenzoate 1 gram, peregal 3 grams, glycerol 40 grams, 440 milliliters of mix homogeneously of distilled water are made water in oil external-application cream.
2, a kind of external preparation for the treatment of skin amyloidosis according to claim 1 is characterized in that: its active ingredient of making is Radix Phytolaccae 90-120 gram, Fructus Gleditsiae Abnormalis 60-80 gram, Fructus Mume 120-170 gram, Galla Chinensis 320-360 gram, Cortex Dictamni 230-280 gram, Herba Centellae 90-140 gram, Camphora 1-2 gram.
3, a kind of external preparation for the treatment of skin amyloidosis according to claim 2 is characterized in that: its active ingredient of making is Radix Phytolaccae 100 grams, Fructus Gleditsiae Abnormalis 70 grams, Fructus Mume 150 grams, Galla Chinensis 350 grams, Cortex Dictamni 250 grams, Herba Centellae 100 grams, Camphora 1 gram.
4, according to claim 1 or 2 or 3 described a kind of external preparation for the treatment of skin amyloidosis, it is characterized in that: it is the stifling extraction of the concentrated solution solid drugs that will fry in shallow oil the back filtering residue that medicinal liquid evaporates, or whole moisture extraction solid drugs are fallen in the concentrated solution natural evaporation of filtering residue after will frying in shallow oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101021424A CN100563683C (en) | 2006-11-11 | 2006-11-11 | A kind of external preparation for the treatment of skin amyloidosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101021424A CN100563683C (en) | 2006-11-11 | 2006-11-11 | A kind of external preparation for the treatment of skin amyloidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1965939A true CN1965939A (en) | 2007-05-23 |
| CN100563683C CN100563683C (en) | 2009-12-02 |
Family
ID=38075032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101021424A Expired - Fee Related CN100563683C (en) | 2006-11-11 | 2006-11-11 | A kind of external preparation for the treatment of skin amyloidosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100563683C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989907A (en) * | 2014-05-29 | 2014-08-20 | 曹红霞 | Traditional Chinese medicine composition for treating amyloidosis cutis |
| CN105770628A (en) * | 2016-05-25 | 2016-07-20 | 王立杰 | Traditional Chinese medicine for treating psoriasis |
-
2006
- 2006-11-11 CN CNB2006101021424A patent/CN100563683C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989907A (en) * | 2014-05-29 | 2014-08-20 | 曹红霞 | Traditional Chinese medicine composition for treating amyloidosis cutis |
| CN105770628A (en) * | 2016-05-25 | 2016-07-20 | 王立杰 | Traditional Chinese medicine for treating psoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100563683C (en) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112315882B (en) | Soothing, repairing and moisturizing cream and preparation method thereof | |
| EP2278986B1 (en) | A product for topical administration | |
| CN1466461A (en) | Antipruritic compositions and compositions promoting wound healing | |
| US20200384055A1 (en) | Topical Skin Care Compositions | |
| Melnyk et al. | Current knowledge on interactions of plant materials traditionally used in skin diseases in Poland and Ukraine with human skin microbiota | |
| Kulawik-Pióro et al. | Plant and herbal extracts as ingredients of topical agents in the prevention and treatment radiodermatitis: a systematic literature review | |
| CN1965939A (en) | Externally applied formulation for treating skin amyloidosis | |
| CN105617020B (en) | Chinese medicine composition and the preparation method and application thereof with skin moisture-keeping effect | |
| CN105267261A (en) | Plant extract combination having skin repair promoting and healing promoting function | |
| WO2022073484A1 (en) | Skin composition and use thereof | |
| CN114306107B (en) | Functional skin product and preparation method thereof | |
| CN110812377B (en) | Acne treatment and repair composition and application thereof | |
| KR102036186B1 (en) | Composition comprising lemon balm extract for lipolysis | |
| CN112870140A (en) | Anti-allergy itching-relieving composition, skin-care gel, and preparation method and application thereof | |
| CN103191163B (en) | Skin wound repairing pharmaceutical composition | |
| CN108853369B (en) | Preparation method and application of natural plant antibacterial liquid PAMs hydrogel patch | |
| CN101185715A (en) | Chinese herbal medicine for treating psoriasis | |
| CN1057213C (en) | Chinese medicinal preparation for treatment skin disease and its prepn. method | |
| CN105853768B (en) | Traditional Chinese medicine formula for treating rheumatoid arthritis and preparation method and application thereof | |
| CN1899520A (en) | Chinese medicine composition for removing wart nevus | |
| CN110856708A (en) | Facial mask liquid and preparation method thereof | |
| CN112716931B (en) | External pharmaceutical composition for improving thyroid nodule | |
| CN115844784B (en) | Composition for relieving inflammation of dry skin and application and preparation method thereof | |
| CN111728903B (en) | Injection and cosmetic composition containing lemon balm extract as active ingredient | |
| CN1247204C (en) | Medicine for treating beri-beri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091202 Termination date: 20101111 |